AbbVie Retained Earnings from 2010 to 2024

ABBV Stock

USD 177.06 0.11 0.06%

AbbVie Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that AbbVie Inc retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2013-03-31

Previous Quarter

-3.8 B

Current Value

-5 B

Quarterly Volatility

2.5 B

Yuan Drop

Covid

Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 B, Interest Expense of 1.1 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.2. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.

Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of AbbVie Inc over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. AbbVie's Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (1000 M)

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

AbbVie Retained Earnings Regression Statistics

	Arithmetic Mean	2,265,933,333
	Geometric Mean	2,031,030,913
	Coefficient Of Variation	88.57
	Mean Deviation	1,631,653,333
	Median	1,567,000,000
	Standard Deviation	2,006,885,735
	Sample Variance	4027590.4T
	Range	6.5B
	R-Value	(0.04)
	Mean Square Error	4329953.5T
	R-Squared	0
	Significance	0.88
	Slope	(18,600,000)
	Total Sum of Squares	56386264.9T

AbbVie Retained Earnings History

	2024	-950 M
	2023	-1000 M
	2022	4.8 B
	2021	3.1 B
	2020	1.1 B
	2019	4.7 B
	2018	3.4 B

Other Fundumenentals of AbbVie Inc

Retained Earnings Total Equity

AbbVie Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Intangible Assets	Property Plant Equipment	Long Term Debt	Short Term Debt	Common Stock	Net Tangible Assets	Retained Earnings	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Treasury Stock	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Current Deferred Revenue
Total Assets		0.35	0.96	0.81	0.93	0.99	-0.4	0.99	0.66	0.97	0.95	0.94	0.78	-0.56	-0.96	0.09	0.95	0.86	0.45	0.02	-0.13	0.63	0.88	-0.32	-0.2	0.33
Total Stockholder Equity	0.35		0.29	0.26	0.46	0.4	-0.26	0.19	-0.24	0.48	0.47	0.07	0.22	0.26	-0.32	-0.21	0.15	0.04	0.1	-0.28	0.75	0.36	0.54	-0.6	-0.08	0.13
Net Debt	0.96	0.29		0.74	0.84	0.96	-0.28	0.95	0.52	0.98	0.89	0.93	0.79	-0.57	-0.96	0.12	0.9	0.82	0.54	0.13	-0.15	0.64	0.85	-0.41	-0.12	0.2
Accounts Payable	0.81	0.26	0.74		0.85	0.83	-0.43	0.8	0.54	0.76	0.81	0.73	0.65	-0.59	-0.87	-0.24	0.79	0.83	0.43	0.02	-0.11	0.51	0.73	-0.46	-0.69	0.68
Net Receivables	0.93	0.46	0.84	0.85		0.95	-0.39	0.89	0.56	0.9	0.97	0.78	0.7	-0.47	-0.87	-0.07	0.83	0.79	0.28	-0.13	0.05	0.61	0.83	-0.46	-0.29	0.48
Good Will	0.99	0.4	0.96	0.83	0.95		-0.38	0.97	0.57	0.98	0.97	0.89	0.77	-0.53	-0.96	0.05	0.91	0.86	0.47	0.04	-0.09	0.63	0.86	-0.43	-0.22	0.38
Short Term Investments	-0.4	-0.26	-0.28	-0.43	-0.39	-0.38		-0.37	-0.36	-0.35	-0.43	-0.33	-0.42	0.44	0.39	0.18	-0.46	-0.44	-0.02	0.34	0.01	-0.33	-0.45	0.03	0.24	-0.24
Total Liab	0.99	0.19	0.95	0.8	0.89	0.97	-0.37		0.73	0.93	0.92	0.97	0.78	-0.63	-0.95	0.13	0.96	0.89	0.45	0.06	-0.27	0.6	0.83	-0.23	-0.19	0.33
Total Current Assets	0.66	-0.24	0.52	0.54	0.56	0.57	-0.36	0.73		0.47	0.54	0.77	0.45	-0.55	-0.56	0.21	0.77	0.65	0.14	-0.11	-0.51	0.3	0.52	0.41	-0.19	0.3
Intangible Assets	0.97	0.48	0.98	0.76	0.9	0.98	-0.35	0.93	0.47		0.94	0.88	0.78	-0.49	-0.95	0.07	0.88	0.79	0.5	0.05	0.0	0.66	0.89	-0.48	-0.14	0.25
Property Plant Equipment	0.95	0.47	0.89	0.81	0.97	0.97	-0.43	0.92	0.54	0.94		0.82	0.77	-0.44	-0.9	-0.14	0.88	0.8	0.31	-0.12	0.06	0.68	0.88	-0.47	-0.26	0.48
Long Term Debt	0.94	0.07	0.93	0.73	0.78	0.89	-0.33	0.97	0.77	0.88	0.82		0.7	-0.64	-0.91	0.2	0.96	0.83	0.49	0.06	-0.36	0.51	0.81	-0.08	-0.15	0.21
Short Term Debt	0.78	0.22	0.79	0.65	0.7	0.77	-0.42	0.78	0.45	0.78	0.77	0.7		-0.48	-0.79	-0.03	0.75	0.73	0.2	0.07	-0.1	0.91	0.72	-0.42	-0.18	0.25
Common Stock	-0.56	0.26	-0.57	-0.59	-0.47	-0.53	0.44	-0.63	-0.55	-0.49	-0.44	-0.64	-0.48		0.57	-0.18	-0.6	-0.76	-0.51	-0.31	0.43	-0.19	-0.34	0.07	0.19	-0.19
Net Tangible Assets	-0.96	-0.32	-0.96	-0.87	-0.87	-0.96	0.39	-0.95	-0.56	-0.95	-0.9	-0.91	-0.79	0.57		-0.01	-0.92	-0.85	-0.5	-0.09	0.16	-0.64	-0.88	0.42	0.36	-0.35
Retained Earnings	0.09	-0.21	0.12	-0.24	-0.07	0.05	0.18	0.13	0.21	0.07	-0.14	0.2	-0.03	-0.18	-0.01		0.01	0.09	0.22	0.51	-0.5	-0.17	-0.16	0.42	0.62	-0.63
Long Term Debt Total	0.95	0.15	0.9	0.79	0.83	0.91	-0.46	0.96	0.77	0.88	0.88	0.96	0.75	-0.6	-0.92	0.01		0.88	0.42	-0.04	-0.27	0.55	0.85	-0.13	-0.28	0.38
Capital Surpluse	0.86	0.04	0.82	0.83	0.79	0.86	-0.44	0.89	0.65	0.79	0.8	0.83	0.73	-0.76	-0.85	0.09	0.88		0.53	0.21	-0.38	0.43	0.63	-0.24	-0.32	0.45
Deferred Long Term Liab	0.45	0.1	0.54	0.43	0.28	0.47	-0.02	0.45	0.14	0.5	0.31	0.49	0.2	-0.51	-0.5	0.22	0.42	0.53		0.44	-0.21	-0.07	0.28	-0.21	-0.12	0.1
Long Term Investments	0.02	-0.28	0.13	0.02	-0.13	0.04	0.34	0.06	-0.11	0.05	-0.12	0.06	0.07	-0.31	-0.09	0.51	-0.04	0.21	0.44		-0.48	-0.09	-0.29	-0.09	0.05	-0.08
Treasury Stock	-0.13	0.75	-0.15	-0.11	0.05	-0.09	0.01	-0.27	-0.51	0.0	0.06	-0.36	-0.1	0.43	0.16	-0.5	-0.27	-0.38	-0.21	-0.48		0.14	0.2	-0.5	-0.01	0.02
Short Long Term Debt	0.63	0.36	0.64	0.51	0.61	0.63	-0.33	0.6	0.3	0.66	0.68	0.51	0.91	-0.19	-0.64	-0.17	0.55	0.43	-0.07	-0.09	0.14		0.69	-0.48	-0.17	0.23
Net Invested Capital	0.88	0.54	0.85	0.73	0.83	0.86	-0.45	0.83	0.52	0.89	0.88	0.81	0.72	-0.34	-0.88	-0.16	0.85	0.63	0.28	-0.29	0.2	0.69		-0.37	-0.3	0.27
Net Working Capital	-0.32	-0.6	-0.41	-0.46	-0.46	-0.43	0.03	-0.23	0.41	-0.48	-0.47	-0.08	-0.42	0.07	0.42	0.42	-0.13	-0.24	-0.21	-0.09	-0.5	-0.48	-0.37		0.31	-0.32
Capital Stock	-0.2	-0.08	-0.12	-0.69	-0.29	-0.22	0.24	-0.19	-0.19	-0.14	-0.26	-0.15	-0.18	0.19	0.36	0.62	-0.28	-0.32	-0.12	0.05	-0.01	-0.17	-0.3	0.31		-0.8
Current Deferred Revenue	0.33	0.13	0.2	0.68	0.48	0.38	-0.24	0.33	0.3	0.25	0.48	0.21	0.25	-0.19	-0.35	-0.63	0.38	0.45	0.1	-0.08	0.02	0.23	0.27	-0.32	-0.8

Click cells to compare fundamentals

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Retained Earnings	-1000 M	-950 M
Retained Earnings Total Equity	5.5 B	3.4 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC